|
Company
Roster
|
Total
Insiders : |
15 |
|
|
Total
Direct Shares :
|
4,795,547 |
|
Total
Indirect Shares :
|
6,793,769 |
|
%
Held by Insiders:
|
23.22% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Reich Siegfried |
VP, Drug Discovery |
2008-08-20 |
0 |
2007-01-16 |
0 |
Papadopoulos Stelios |
Director |
2006-02-06 |
35,930 |
2006-02-06 |
0 |
Myers W Todd |
CFO |
2008-08-20 |
0 |
2006-12-05 |
0 |
Lathi Vijay K |
Director |
2006-02-06 |
0 |
2006-02-06 |
1,406,967 |
Henney Christopher S |
Director |
2008-08-20 |
0 |
|
0 |
Grey Michael G |
President & CEO, Director |
|
0 |
2008-08-20 |
0 |
Formela Jean Francois |
Director, 10% Owner |
2006-02-01 |
0 |
2006-02-06 |
2,485,068 |
Eastham Karin |
Director |
2008-08-20 |
0 |
|
0 |
Bvf Investments Llc |
10% Owner |
2007-02-14 |
1,655,300 |
|
0 |
Burley Stephen |
CSO & SVP, Research |
2008-08-20 |
0 |
|
0 |
Bock Louis C |
Director, 10% Owner |
2006-02-06 |
0 |
2008-08-20 |
0 |
Biotechnology Value Fund Ii Lp |
10% Owner |
2008-04-04 |
3,104,317 |
|
0 |
Bavp, L.p. |
10% Owner |
2008-08-20 |
0 |
2006-02-06 |
0 |
Atlas Venture Fund Iii L P |
10% Owner |
2006-02-06 |
0 |
2006-02-06 |
2,485,068 |
Atlas Venture Associates Iv, L.p. |
10% Owner |
2006-02-01 |
0 |
2006-02-01 |
416,666 |
|
|